P58 Chemotherapy treatment for prostate cancer in the elderly: a comparison between docetaxel reduced dose in patients over 70 years old versus docetaxel standard dose in patients under 70doi:10.1016/S1040-8428(09)70096-4E. Ceballos and P. Hernández and S. Moreno and N. Lupión and F. ...
P58 Chemotherapy treatment for prostate cancer in the elderly: a comparison between docetaxel reduced dose in patients over 70 years old versus docetaxel s... ECHML Aranda - 《Critical Reviews in Oncology/hematology》 被引量: 0发表: 2009年 A weekly schedule of low dose of docetaxel in the ...
We report the results of a retrospective analysis of localized prostate cancer (LPCa) treated with transperineal ultrasound image-guided radiotherapy (TPUS-IGRT). Methods A total of 124 patients (median age: 74 y, 46–84 y) with LPCa who underwent TPUS-IGRT (Clarity Autoscan system; CAS, El...
but which of these risk factors cause a prostate cell to become cancerous is not fully known. For a cancer to develop, changes must occur in the chemicals that make up the DNA, which makes up the genes in the cell. The genes control how the cell ...
Age: Sixty percent of cases of prostate cancer arise in men over 65 years of age. The disease is rare in men under 40. Race or ethnicity: African-American men and Jamaican men of African ancestry are diagnosed with prostate cancer more often than are men of other races and ethnicities. ...
Financial toxicity is increasingly recognized in oncology but has been poorly studied in the context of prostate cancer. A high risk of developing financial distress might influence a patient’s treatment decisions; however, no guidelines recommend explicit discussion of this topic. A patient’s risk...
There is questioning among healthcare professionals regarding the over-diagnosis and overtreatment of prostate cancer. However, screening to see if cancer is present is still important. If the doctor suspects cancer, then he may decide to proceed with a prostate biopsy. We recognize that not all ...
GVAX: an allogeneic, whole-cell, GM-CSF-secreting cellular immunotherapy for the treatment of prostate cancer. Antitumor vaccines, also known as active immunotherapies, have become an intense focus of research over the last decade as a means to ideally provide new t... Ward JEMcNeel DG - 《...
Age: Sixty percent of cases of prostate cancer arise in men over 65 years of age. The disease is rare in men under 40. Race or ethnicity: African-American men and Jamaican men of African ancestry are diagnosed with prostate cancer more often than are men of other races and ethnicities. ...
Ionizing radiation acoustic imaging (iRAI) allows online monitoring of radiation’s interactions with tissues during radiation therapy, providing real-time, adaptive feedback for cancer treatments. We describe an iRAI volumetric imaging system that enables mapping of the three-dimensional (3D) radiation ...